Carbamazepine and oxcarbazepine for the treatment of behavioural and psychological symptoms of dementia (BPSD)

This review has been withdrawn.

The reason for withdrawal and previous versions are archived and accessible within the withdrawn record in the Cochrane Library.

Health topics:

Mental health > Dementia & cognition > Interventions aimed at manifestations of the disease

Neurology > Dementia & cognition > Treatment aimed at manifestations of the disease

Published:

3 August 2018

Authors:

Tampi R, Aziz R, Kantrowitz J, Zdanys K

Was this helpful? Donate.

If you found this evidence helpful, please consider donating to Cochrane. We are a charity that produces accessible evidence to help people make health and care decisions.
Donate
Print
PDF
Citation
Tampi R, Aziz R, Kantrowitz J, Zdanys K. Carbamazepine and oxcarbazepine for the treatment of behavioural and psychological symptoms of dementia (BPSD). Cochrane Database of Systematic Reviews 2018, Issue 8. Art. No.: CD007761. DOI: 10.1002/14651858.CD007761.pub2